PatientsVille.com Logo

PatientsVille

Ciprobay Side Effects

Common Ciprobay Side Effects


The most commonly reported Ciprobay side effects (click to view or check a box to report):

Renal Failure Acute (7)
Nausea (6)
Joint Swelling (5)
Diarrhoea (5)
Asthenia (4)
Blood Creatinine Increased (4)
Dyspnoea (4)
Weight Decreased (4)
Rhabdomyolysis (4)
Abdominal Discomfort (3)
Alopecia (3)
Automatic Bladder (3)
Blood Pressure Fluctuation (3)
Arthralgia (3)
Vomiting (3)
Renal Failure (3)
Periorbital Oedema (3)
Eye Disorder (3)
Dehydration (3)
Constipation (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Ciprobay Side Effects Reported to FDA

The following Ciprobay reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Ciprobay on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anaphylactic Reaction
This is a report of a 17-year-old female patient (weight: NA) from ZA, suffering from the following symptoms/conditions: NA, who was treated with Ciprobay Xr 1000 (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Anaphylactic Reaction
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ciprobay Xr 1000 treatment in female patients, resulting in anaphylactic reaction side effect.


This report suggests a potential Ciprobay side effect(s) that can have serious consequences. A 42-year-old male patient (weight: NA) from MY was diagnosed with the following symptoms/conditions: white blood cell count increased,diarrhoea and used Ciprobay (dosage: 200 Mg, Bid) starting NS. Soon after starting Ciprobay the patient began experiencing various side effects, including:
    Drugs used concurrently: NA. Although Ciprobay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

    Joint Swelling, Local Swelling, Erythema, Exostosis
    This Joint Swelling, Local Swelling, Erythema, Exostosis problem was reported by a physician from DE. A 72-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: prostatitis escherichia coli,joint swelling. On Oct 05, 2013 this consumer started treatment with Ciprobay (dosage: 500 Mg, Bid). The following drugs were being taken at the same time:
    • Ibuprofen (Unk)
    • Ibuprofen (Unk)
    • Cotrim
    • Cefuroxim
    When commencing Ciprobay, the patient experienced the following unwanted symptoms/side effects:
    • Joint Swelling
    • Local Swelling
    • Erythema
    • Exostosis
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as joint swelling, may become evident only after a product is in use by the general population.

    Skin Necrosis, Skin Ulcer, Type Iv Hypersensitivity Reaction, Dry Skin
    This is a report of a female patient (weight: NA) from DE. The patient developed the following symptoms/conditions: bronchitis and was treated with Ciprobay (dosage: 250 Mg, Bid) starting Sep 23, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Skin Necrosis
    • Skin Ulcer
    • Type Iv Hypersensitivity Reaction
    • Dry Skin
    This opens a possibility that Ciprobay treatment could cause the above reactions, including skin necrosis, and some female subjects may be more susceptible.


    Anxiety, Feeling Abnormal, Local Swelling, Lacrimation Increased, Emotional Disorder
    A 46-year-old female patient (weight: NA) from US with the following symptoms/conditions: kidney infection started Ciprobay treatment (dosage: 1 Once Daily) on Jul 10, 2013. Soon after starting Ciprobay treatment, the subject experienced various side effects, including:
    • Anxiety
    • Feeling Abnormal
    • Local Swelling
    • Lacrimation Increased
    • Emotional Disorder
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Ciprobay.

    Rash, Liver Disorder, Polyneuropathy, C-reactive Protein Increased, Dermatitis, Staphylococcal Infection, Transaminases Increased, Asthenia
    A 78-year-old female patient from US (weight: NA) experienced symptoms, such as: pneumonia and was treated with Ciprobay [ciprofloxacin Hydrochloride](dosage: 800 Mg (daily Dose), , Intravenous). The treatment was initiated on Feb 23, 1998. After that a consumer reported the following side effect(s):
    • Rash
    • Liver Disorder
    • Polyneuropathy
    • C-reactive Protein Increased
    • Dermatitis
    • Staphylococcal Infection
    • Transaminases Increased
    • Asthenia
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Ciprobay [ciprofloxacin Hydrochloride] efficacy:
    • Clemastine
    • Cortisone [cortisone]
    • Ketamine
    • Midazolam
    • Theophylline
    • Reproterol
    • Sucralfate
    • Heparin
    The patient was hospitalized.

    Chest Wall Mass, Enteritis, Gastritis, Helicobacter Infection, Neuropathy Peripheral, Optic Neuropathy, Respiratory Failure, Steatorrhoea
    In this report, Ciprobay was administered for the following condition: bovine tuberculosis.A 15-year-old male consumer from US (weight: NA) started Ciprobay treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Chest Wall Mass
    • Enteritis
    • Gastritis
    • Helicobacter Infection
    • Neuropathy Peripheral
    • Optic Neuropathy
    • Respiratory Failure
    • Steatorrhoea
    A possible interaction with other drugs could have contributed to this reaction:
    • Clarithromycin
    • Ethionamide
    • Rifabutin
    • Amoxi-clavulanico
    • Streptomycin
    • Ofloxacin
    • Linezolid
    • Interferon Gamma
    Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Ciprobay treatment could be related to the listed above side effect(s).

    Blood Creatinine Increased, Renal Failure Acute, Haemoglobin Decreased, Liver Function Test Abnormal, Hepatic Steatosis
    This is a report of the following Ciprobay side effect(s):
    • Blood Creatinine Increased
    • Renal Failure Acute
    • Haemoglobin Decreased
    • Liver Function Test Abnormal
    • Hepatic Steatosis
    A 64-year-old female patient from DE (weight: NA) presented with the following condition: NA and received a treatment with Ciprobay (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Ciprobay treatment could be associated with the listed above side effect(s).

    Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Red Blood Cell Sedimentation Rate Increased, Hypertension, Tubulointerstitial Nephritis, Isosthenuria
    This Ciprobay report was submitted by a 32-year-old male consumer from DE (weight: NA). The patient was diagnosed with: NA and Ciprobay was administered (dosage: 250 Mg, Unk) starting: NS. The consumer developed a set of symptoms:
    • Blood Creatinine Increased
    • Creatinine Renal Clearance Decreased
    • Red Blood Cell Sedimentation Rate Increased
    • Hypertension
    • Tubulointerstitial Nephritis
    • Isosthenuria
    Other drugs used simultaneously:
    • Acetylsalicylic Acid
    Those unexpected symptoms could be linked to a Ciprobay treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Angina Pectoris, Cerebral Disorder, Arrhythmia, Malaise, Nausea, Dyspnoea, Oliguria, Thirst, Swelling
    This is a report of a possible correlation between Ciprobay use and the following symptoms/side effect(s):
    • Angina Pectoris
    • Cerebral Disorder
    • Arrhythmia
    • Malaise
    • Nausea
    • Dyspnoea
    • Oliguria
    • Thirst
    • Swelling
    which could contribute to an assessment of Ciprobay risk profile.A 70-year-old male consumer from DE (weight: NA) was suffering from NA and was treated with Ciprobay (dosage: 750 Df, Unk) starting NS.Other concurrent medications:
    • Hepaticum-medice


    Acute Abdomen, Nausea, Vomiting
    A 23-year-old female patient from DE (weight: NA) presented with the following symptoms: NA and after a treatment with Ciprobay (dosage: 250, Unk, Unk) experienced the following side effect(s):
    • Acute Abdomen
    • Nausea
    • Vomiting
    The treatment was started on NS. Ciprobay was used in combination with the following drugs: NA.This report could alert potential Ciprobay consumers.

    Gastroenteritis, Cholestasis, Gamma-glutamyltransferase Increased, Liver Tenderness, Faeces Pale, Diarrhoea, Malaise, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
    In this report, a male patient from DE (weight: NA) was affected by a possible Ciprobay side effect.The patient was diagnosed with NA. After a treatment with Ciprobay (dosage: 250 Mg, Unk, start date: NS), the patient experienced the following side effect(s):
    • Gastroenteritis
    • Cholestasis
    • Gamma-glutamyltransferase Increased
    • Liver Tenderness
    • Faeces Pale
    • Diarrhoea
    • Malaise
    • Aspartate Aminotransferase Increased
    • Blood Alkaline Phosphatase Increased
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Ciprobay treatment.

    Brain Oedema, Status Epilepticus, Renal Failure Acute, Monoparesis
    This is a report of a 52-year-old female patient from DE (weight: NA), who used Ciprobay (dosage: 200 Unk, Unk) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
    • Brain Oedema
    • Status Epilepticus
    • Renal Failure Acute
    • Monoparesis
    The following drugs could possibly have interacted with the Ciprobay treatment
    • Baypen (4 G, Unk)
    • Metronidazol
    • Beloc
    Taken together, these observations suggest that a Ciprobay treatment could be related to side effect(s), such as Brain Oedema, Status Epilepticus, Renal Failure Acute, Monoparesis.

    Renal Function Test Abnormal, Renal Failure, Nausea, Decreased Appetite, Hyperhidrosis, Sleep Disorder, Blood Creatinine Increased
    This renal function test abnormal side effect was reported by a physician from DE. A 85-year-old male patient (weight:NA) experienced the following symptoms/conditions: prostatitis. The patient was prescribed Ciprobay (dosage: 500 Mg, Unk), which was started on Nov 28, 2008. Concurrently used drugs:
    • Delix
    • Ramipril
    • Metformin Hydrochloride
    • Simvastatin (10 Mg, Unk)
    • Crataegutt Novo (2 Df, Unk)
    • Marcumar (3 Mg, Unk)
    • Phenprocoumon
    • Allopurinol (150 Mg, Unk)
    When starting to take Ciprobay the consumer reported the following symptoms:
    • Renal Function Test Abnormal
    • Renal Failure
    • Nausea
    • Decreased Appetite
    • Hyperhidrosis
    • Sleep Disorder
    • Blood Creatinine Increased
    These side effects may potentially be related to Ciprobay.

    Ventricular Tachycardia
    This is a Ciprobay side effect report of a 39-year-old male patient (weight:NA) from TH, suffering from the following symptoms/conditions: diarrhoea,pyrexia, who was treated with Ciprobay (dosage:400 Mg, Unk, start time: NS), combined with: NA., and developed a serious reaction and a ventricular tachycardia side effect. The patient presented with:
    • Ventricular Tachycardia
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Ciprobay treatment in male patients suffering from diarrhoea,pyrexia, resulting in ventricular tachycardia.

    Toxic Epidermal Necrolysis
    This report suggests a potential Ciprobay toxic epidermal necrolysis side effect(s) that can have serious consequences. A 61-year-old male patient from DE (weight:NA) was diagnosed with the following health condition(s): NA and used Ciprobay (dosage: NA) starting Jan 11, 2013. Soon after starting Ciprobay the patient began experiencing various side effects, including:
    • Toxic Epidermal Necrolysis
    Drugs used concurrently:
    • Beloc Zok (metoprolol Succinate)
    • Tazobac
    • Taurolin
    The patient was hospitalized. Although Ciprobay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as toxic epidermal necrolysis, may still occur.

    Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Traumatic Renal Injury
    This blood creatine phosphokinase increased problem was reported by a consumer or non-health professional from DE. A 85-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): urinary tract infection.On NS a consumer started treatment with Ciprobay (dosage: Unk). The following drugs/medications were being taken at the same time:
    • Zocor
    When commencing Ciprobay, the patient experienced the following unwanted symptoms /side effects:
    • Blood Creatine Phosphokinase Increased
    • Rhabdomyolysis
    • Traumatic Renal Injury
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as blood creatine phosphokinase increased, may become evident only after a product is in use by the general population.

    Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Myalgia, Myopathy, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
    This is a Ciprobay side effect report of a 39-year-old male patient (weight: NA) from DE. The patient developed the following symptoms/conditions: epididymitis and was treated with Ciprobay (dosage: Daily Dose 500 Mg) starting Mar 04, 2013. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Blood Creatine Phosphokinase Increased
    • Rhabdomyolysis
    • Myalgia
    • Myopathy
    • Aspartate Aminotransferase Increased
    • Alanine Aminotransferase Increased
    This opens a possibility that Ciprobay could cause blood creatine phosphokinase increased and that some male patients may be more susceptible.

    Rhabdomyolysis, Renal Failure
    A 32-year-old female patient (weight: NA) from DE with the following symptoms: NA started Ciprobay treatment (dosage: Unk) on NS. Soon after starting Ciprobay treatment, the consumer experienced several side effects, including:
    • Rhabdomyolysis
    • Renal Failure
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Ciprobay side effects, such as rhabdomyolysis.

    Circulatory Collapse, Asthenia, Visual Impairment
    This circulatory collapse side effect was reported by a physician from DE. A 78-year-old male patient (weight:NA) experienced the following symptoms/conditions: diverticulitis.The patient was prescribed Ciprobay (dosage: 500 Mg, Bid), which was started on NS. Concurrently used drugs:
    • Metronidazol
    • Marcumar
    • Marcumar
    • Lorzaar
    .When starting to take Ciprobay the consumer reported symptoms, such as:
    • Circulatory Collapse
    • Asthenia
    • Visual Impairment
    These side effects may potentially be related to Ciprobay.

    Hepatic Function Abnormal
    This is a report of a 46-year-old female patient (weight: NA) from CN, suffering from the following symptoms/conditions: NA, who was treated with Ciprobay (dosage: 0.2 G, Bid, start time: Mar 30, 2010), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Hepatic Function Abnormal
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ciprobay treatment in female patients, resulting in hepatic function abnormal side effect.

    Leukopenia, Granulocytopenia, Vomiting, Dizziness, Nausea
    This report suggests a potential Ciprobay Leukopenia, Granulocytopenia, Vomiting, Dizziness, Nausea side effect(s) that can have serious consequences. A 59-year-old male patient (weight: NA) from CN was diagnosed with the following symptoms/conditions: lung infection and used Ciprobay (dosage: 200 Ml, Qd) starting Jul 14, 2010. Soon after starting Ciprobay the patient began experiencing various side effects, including:
    • Leukopenia
    • Granulocytopenia
    • Vomiting
    • Dizziness
    • Nausea
    Drugs used concurrently: NA. Although Ciprobay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as leukopenia, may still occur.

    Cholestatic Liver Injury, Jaundice, Faeces Discoloured, Chromaturia, Weight Decreased, Hepatomegaly, Pruritus
    This Cholestatic Liver Injury, Jaundice, Faeces Discoloured, Chromaturia, Weight Decreased, Hepatomegaly, Pruritus problem was reported by a health professional from SI. A 19-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: upper respiratory tract infection. On 201102 this consumer started treatment with Ciprobay (dosage: 500 Mg, Bid). The following drugs were being taken at the same time: NA. When commencing Ciprobay, the patient experienced the following unwanted symptoms/side effects:
    • Cholestatic Liver Injury
    • Jaundice
    • Faeces Discoloured
    • Chromaturia
    • Weight Decreased
    • Hepatomegaly
    • Pruritus
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as cholestatic liver injury, may become evident only after a product is in use by the general population.

    Bone Pain, Groin Pain, Musculoskeletal Pain, Pain In Extremity
    This is a report of a 54-year-old female patient (weight: NA) from DE. The patient developed the following symptoms/conditions: diverticulitis and was treated with Ciprobay (dosage: Unk) starting 201111. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Bone Pain
    • Groin Pain
    • Musculoskeletal Pain
    • Pain In Extremity
    The patient was hospitalized. This opens a possibility that Ciprobay treatment could cause the above reactions, including bone pain, and some female subjects may be more susceptible.

    Periorbital Oedema
    A 15-year-old male patient (weight: NA) from SINGAPORE with the following symptoms/conditions: NA started Ciprobay 100 Infusion 100 Mg/50 Ml treatment (dosage: NA) on NS. Soon after starting Ciprobay 100 Infusion 100 Mg/50 Ml treatment, the subject experienced various side effects, including:
    • Periorbital Oedema
    Concurrently used drugs:
    • Amoxicillin
    • Cefazolin
    • Erythromycin
    • Clindamycin
    • Vancomycin
    This finding indicates that some male patients could be more vulnerable to Ciprobay 100 Infusion 100 Mg/50 Ml.

    1 of 2 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Ciprobay Side Effects

    Did You Have a Ciprobay Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ciprobay for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective